Table 2.
Multivariate analyses of F5 in the prediction of gastric cancer overall survival.
| Variables | HR (95% CI) | P value |
|---|---|---|
| F5 (high vs. low) | 1.533 (1.029, 2.284) | 0.036 |
| Age (years) (≥60 vs. <60) | 1.581 (1.029, 2.429) | 0.037 |
| Pathological M (M1 vs. M0) | 1.129 (0.407, 3.132) | 0.816 |
| Pathological T (T3/4 vs. T1/2) | 1.051 (0.559, 1.978) | 0.877 |
| TNM stage | ||
| Stage II vs. stage I | 2.058 (0.727, 5.830) | 0.174 |
| Stage III vs. stage I | 2.562 (0.895, 7.330) | 0.079 |
| Stage IV vs. stage I | 3.014 (0.931, 9.758) | 0.066 |
| Radiation therapy (no vs. yes) | 1.467 (0.771, 2.791) | 0.243 |
| Targeted molecular therapy (no vs. yes) | 1.367 (0.861, 2.170) | 0.185 |
| Cancer status (yes vs. no) | 5.193 (3.296, 8.183) | <0.001 |
Abbreviations: F5—Coagulation factor V; HR—hazard ratio; CI—confidence interval; T—tumour; N—node; M—metastasis.